Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 24,643 | -7,117 | 122,873 | 107,839 | 106,841 |
| Depreciation Amortization | 239,491 | 115,613 | 225,358 | 93,366 | 36,969 |
| Income taxes - deferred | -65,275 | -45,091 | -57,789 | -45,990 | -11,160 |
| Accounts receivable | -124,206 | -36,393 | -49,914 | -36,953 | -28,237 |
| Accounts payable and accrued liabilities | 11,561 | -5,753 | -14,223 | -7,952 | -2,769 |
| Other Working Capital | -159,675 | -42,718 | -116,598 | -71,198 | -69,605 |
| Other Operating Activity | 180,106 | 73,846 | 133,792 | 99,713 | 56,302 |
| Operating Cash Flow | $106,645 | $52,387 | $243,499 | $138,825 | $88,341 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,113 | 2,650 | 777,913 | 434,417 | 181,116 |
| PPE Investments | -56,366 | -28,568 | -78,274 | -55,393 | -33,859 |
| Net Acquisitions | -17,535 | -12,649 | -296,028 | -296,028 | -2,662 |
| Purchase Of Investment | -12,174 | -8,017 | -100,643 | -100,643 | -81,381 |
| Investing Cash Flow | $-56,962 | $-46,584 | $302,968 | $-17,647 | $63,214 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,651 | 3,413 | 12,397 | 11,357 | 8,058 |
| Common Stock Repurchased | -84,787 | -83,316 | -225,562 | N/A | N/A |
| Other Financing Activity | -39,876 | -35,818 | -18,656 | -5,908 | -4,034 |
| Financing Cash Flow | $-107,012 | $-115,721 | $-231,821 | $5,449 | $4,024 |
| Exchange Rate Effect | 461 | -3,312 | 2,180 | 2,527 | 407 |
| Beginning Cash Position | 467,292 | 467,292 | 150,466 | 150,466 | 150,466 |
| End Cash Position | 410,424 | 354,062 | 467,292 | 279,620 | 306,452 |
| Net Cash Flow | $-56,868 | $-113,230 | $316,826 | $129,154 | $155,986 |
| Free Cash Flow | |||||
| Operating Cash Flow | 106,645 | 52,387 | 243,499 | 138,825 | 88,341 |
| Capital Expenditure | -56,366 | -28,568 | -78,274 | -55,393 | -33,859 |
| Free Cash Flow | 50,279 | 23,819 | 165,225 | 83,432 | 54,482 |